Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Logan Paul’s energy drink with the caffeine of six Coke cans faces calls for FDA probe

An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine

The Independent UK

The FDA is being asked to look into Logan Paul's energy drink, which has the caffeine of 6 Coke cans

An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine

The Independent UK

Tennessee Ban on Sexual-Identity-Related Medical Procedures for Minors Is Likely Constitutional,

a Sixth Circuit panel concludes (by a 2-1 vote) in staying an injunction against the law pending appeal.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

F.D. Flam: Cancer risk or no, diet soda is bad for you

There were good reasons to avoid products with the artificial sweetener aspartame even before the World Health Organization classified it as a “possible carcinogen” last month. But now diet soda drinkers might really want to put down the can.

Tribune News Service

Bryan Johnson admits he saw 'no benefits’ after injecting his son’s plasma

Johnson underwent “the world’s first multigenerational plasma exchange" with his son and father, despite warnings against it.

Fortune

FDA Approves Biogen’s Alzheimer’s Drug That Slows Down Cognitive Decline

The FDA fully approved Biogen Inc. but there are other companies with treatments in the pipeline

Zenger

Up First Briefing: Alzheimer's drug; Ukraine cluster bombs; tap water chemicals

The FDA approved the first drug shown to slow down Alzheimer's. The Biden administration will send controversial cluster bombs to Ukraine. A study estimates PFAS is in nearly half of U.S. tap water.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

The Independent UK

FDA approves new Alzheimer's drug

Leqembi has proven to slow the progression of the disease, while others only target its symptoms

Salon

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Al Jazeera

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Tribune News Service

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Axios

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Roll Call

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Daily Mirror

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

StockNews.com

AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top?

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Test approved to detect preeclampsia, leading cause of US maternal deaths

FDA approves new test, which has been widely celebrated as a small victory in the fight to make childbirth safer in the US

Axios

The plan to dodge another tripledemic

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

Tribune News Service

As low-nicotine cigarettes hit the market, anti-smoking groups press for wider standard

The idea seems simple enough.

Salon

Is aspartame actually that harmful?

"While reports like these can understandably be worrying, there's no reason to panic at this stage"

Inverse

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

The Conversation

According to reports, the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), is set to declare the artificial sweetener aspartame as “possibly carcinogenic to humans”.

Marie Claire

Exosome Therapy Is Ushering in the Next Generation of Skin and Hair Rejuvenation

“Think of exosomes as the body’s own information superhighway.”

1 … 123 124 125 126

People

Mangeet Kaur BounsMangeet

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Food and Drug Administration

208 stories

Biogen

198 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.